A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study
This scoping review examines the role of digital solutions in active, participant-centered surveillance of adverse events following initial release of COVID-19 vaccines. The goals of this paper were to examine the existing literature surrounding digital solutions and technology used for active, part...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2293550 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850185485249413120 |
|---|---|
| author | Mohamed Serhan Athanasios Psihogios Nooh Kabir A. Brianne Bota Salima S. Mithani David P. Smith David T. Zhu Devon Greyson Sarah Wilson Deshayne Fell Karina A. Top Julie A. Bettinger Kumanan Wilson |
| author_facet | Mohamed Serhan Athanasios Psihogios Nooh Kabir A. Brianne Bota Salima S. Mithani David P. Smith David T. Zhu Devon Greyson Sarah Wilson Deshayne Fell Karina A. Top Julie A. Bettinger Kumanan Wilson |
| author_sort | Mohamed Serhan |
| collection | DOAJ |
| description | This scoping review examines the role of digital solutions in active, participant-centered surveillance of adverse events following initial release of COVID-19 vaccines. The goals of this paper were to examine the existing literature surrounding digital solutions and technology used for active, participant centered, AEFI surveillance of novel COVID-19 vaccines approved by WHO. This paper also aimed to identify gaps in literature surrounding digital, active, participant centered AEFI surveillance systems and to identify and describe the core components of active, participant centered, digital surveillance systems being used for post-market AEFI surveillance of WHO approved COVID-19 vaccines, with a focus on the digital solutions and technology being used, the type of AEFI detected, and the populations under surveillance. The findings highlight the need for customized surveillance systems based on local contexts and the lessons learned to improve future vaccine monitoring and pandemic preparedness. |
| format | Article |
| id | doaj-art-f9ac0564af6e4021a0f9de9465e2a5f5 |
| institution | OA Journals |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-f9ac0564af6e4021a0f9de9465e2a5f52025-08-20T02:16:44ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2024-12-0120110.1080/21645515.2023.2293550A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network studyMohamed Serhan0Athanasios Psihogios1Nooh Kabir2A. Brianne Bota3Salima S. Mithani4David P. Smith5David T. Zhu6Devon Greyson7Sarah Wilson8Deshayne Fell9Karina A. Top10Julie A. Bettinger11Kumanan Wilson12Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, CanadaClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, CanadaClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, CanadaClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, CanadaClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, CanadaDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, CanadaClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, CanadaSchool of Population and Public Health, University of British Columbia, Vancouver, CanadaHealth Protection, Public Health Ontario, Toronto, ON, CanadaDepartment of Pediatrics, Children’s Hospital of Eastern Ontario (CHEO) Research Institute, Ottawa, CanadaDepartment of Pediatrics, University of Alberta, Edmonton, AB, CanadaVaccine Evaluation Center, Department of Pediatrics, BC Children’s Hospital Research Institute, University of British Columbia, Vancouver, CanadaClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, CanadaThis scoping review examines the role of digital solutions in active, participant-centered surveillance of adverse events following initial release of COVID-19 vaccines. The goals of this paper were to examine the existing literature surrounding digital solutions and technology used for active, participant centered, AEFI surveillance of novel COVID-19 vaccines approved by WHO. This paper also aimed to identify gaps in literature surrounding digital, active, participant centered AEFI surveillance systems and to identify and describe the core components of active, participant centered, digital surveillance systems being used for post-market AEFI surveillance of WHO approved COVID-19 vaccines, with a focus on the digital solutions and technology being used, the type of AEFI detected, and the populations under surveillance. The findings highlight the need for customized surveillance systems based on local contexts and the lessons learned to improve future vaccine monitoring and pandemic preparedness.https://www.tandfonline.com/doi/10.1080/21645515.2023.2293550Adverse events following immunization (AEFI)vaccine safety surveillanceactive surveillancepost-marketing surveillanceparticipant reportingpharmacovigilance |
| spellingShingle | Mohamed Serhan Athanasios Psihogios Nooh Kabir A. Brianne Bota Salima S. Mithani David P. Smith David T. Zhu Devon Greyson Sarah Wilson Deshayne Fell Karina A. Top Julie A. Bettinger Kumanan Wilson A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study Human Vaccines & Immunotherapeutics Adverse events following immunization (AEFI) vaccine safety surveillance active surveillance post-marketing surveillance participant reporting pharmacovigilance |
| title | A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study |
| title_full | A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study |
| title_fullStr | A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study |
| title_full_unstemmed | A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study |
| title_short | A scoping review of active, participant centred, digital adverse events following immunization (AEFI) surveillance of WHO approved COVID-19 vaccines: A Canadian immunization Research Network study |
| title_sort | scoping review of active participant centred digital adverse events following immunization aefi surveillance of who approved covid 19 vaccines a canadian immunization research network study |
| topic | Adverse events following immunization (AEFI) vaccine safety surveillance active surveillance post-marketing surveillance participant reporting pharmacovigilance |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2023.2293550 |
| work_keys_str_mv | AT mohamedserhan ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT athanasiospsihogios ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT noohkabir ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT abriannebota ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT salimasmithani ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT davidpsmith ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT davidtzhu ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT devongreyson ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT sarahwilson ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT deshaynefell ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT karinaatop ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT julieabettinger ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT kumananwilson ascopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT mohamedserhan scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT athanasiospsihogios scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT noohkabir scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT abriannebota scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT salimasmithani scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT davidpsmith scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT davidtzhu scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT devongreyson scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT sarahwilson scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT deshaynefell scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT karinaatop scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT julieabettinger scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy AT kumananwilson scopingreviewofactiveparticipantcentreddigitaladverseeventsfollowingimmunizationaefisurveillanceofwhoapprovedcovid19vaccinesacanadianimmunizationresearchnetworkstudy |